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Key Clinical Message
The loss of ANKRD11 gene confirms the diagnosis of KBG syndrome but does
not elucidate the pediatric phenotype providing a counseling challenge. With
the expansion of prenatal diagnosis, and the potential to perform whole-exome
sequencing antenatally, we must describe the genetic abnormalities, antenatal
ultrasound findings, and phenotype concurrently to facilitate counseling.
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Introduction
KBG syndrome was first described by Herrmann [1] and
is associated with distinct dental, craniofacial, neurobe-
havioral, and skeletal anomalies, macrodontia of the
upper central incisors of the permanent teeth being the
dominant diagnostic feature [2]. Whole-exome sequenc-
ing (WES) of affected individuals has recently identified
mutations in ANKRD11 as causative of the disorder [2].
KBG syndrome can occur due to various loss of function
alterations in ANKRD11, or as a result of known 16q24
microdeletions encompassing ANKRD11. ANKRD11
encodes ankyrin repeat domain 11, which interacts with
nuclear receptor complexes to alter transcription localiz-
ing to the nuclei of neurons, accumulating in discrete
inclusions in neurons, thus supporting the role of
ANKRD11 in neural plasticity [3]. Diagnosis of KBG syn-
drome is possible in the neonatal period; however, the
clinical signs can manifest mildly with few associated
medical complications and as such diagnosis can be
entirely missed or delayed. More often, diagnosis is made
at 7–8 years of age following eruption of the upper per-
manent central incisors. Hence, it is suspected that KBG
syndrome is an underdiagnosed condition.
Case Report
We report the first known antenatally diagnosed case of a
microdeletion at chromosome 16q24.2q24.3 encompassing
ANKRD11, identified on array comparative genomic
hybridization (aCGH) as causative for KBG syndrome in
the fetus. We report the postmortem findings, which were
confirmative of the expected phenotype associated with
16q24 microdeletion including ANKRD11, and discuss
the rapidly evolving area of prenatal diagnosis in relation
to the importance of appropriate counseling and support
for families undergoing genetic testing.
A 32-year-old nulliparous woman was referred to a ter-
tiary Fetal Medicine Centre at 21 weeks of gestation with
suspected fetal echogenic bowel. A detailed ultrasound
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assessment demonstrated calcified foci in the upper abdo-
men (liver) (Fig. 1A). Cystic fibrosis carrier testing and
infection screening were undertaken and reported as neg-
ative. An amniocentesis was performed, and chromosomal
microarray (CMA) demonstrated a male fetus with a
deletion of approximately 1.86 Mb at chromosome 16
band q24.2q24 [3]. The deleted region ISCN nomencla-
ture for the deletion arr [GRCh37] 16q24.2q24.3
(87614996_89479537) x1 dn contained 26 genes from
JPH3 including ANKRD11. A diagnosis of KBG syndrome
was prospectively made. Targeted parental CMA testing
demonstrated that the microdeletion occurred de novo in
the fetus.
After counseling and consideration, the parents pro-
ceeded with termination of pregnancy at 27 + 5 weeks of
gestation resulting in delivery of a male fetus weighing
950 g. Postmortem examination identified multiple exter-
nal congenital anomalies including a triangularly shaped
face, mildly low-set ears, and a right retained testis. Inter-
nal congenital anomalies included incomplete lobation of
the left lung, lobulated spleen, cervical ribs, irregularity of
vertebral body C1-4, and calcification of the liver associ-
ated with the portal tracts.
Discussion
The facial and skeletal features identified at postmortem
are consistent with KBG syndrome. The gastrointestinal
abnormalities reported, specifically the calcification of the
portal tracts in the liver, have not previously been associ-
ated with this syndrome and may therefore represent a
more severe phenotype, likely due to the complete loss of
ANKRD11 in addition to the loss of any of the other 25
genes located on this segment of the chromosome.
Low et al. [4] have reported the clinical and genetic
aspects of KBG syndrome in 30 children following devel-
opment of a single gene diagnostic test for the condition
in 2014. There were no antenatal diagnoses of KBG
syndrome, and on retrospective review of their prenatal
anomaly scans, there was one cardiac condition identified
and one single umbilical artery. Both KBG syndrome and
16q24 microdeletion syndrome have been associated with
small for gestational age fetuses and polyhydramnios [4].
Antenatal diagnosis in this first reported antenatal case
is secondary to performing invasive testing following
identification of fetal liver calcification. There is an
important association between liver calcification and
chromosomal abnormalities with a 50% versus 20% sig-
nificant difference in matched controls with and without
antenatal identification of liver calcification [5].
The KBG diagnosis, although supported by the congen-
ital abnormalities observed at postmortem examination,
does not fully elucidate the neonatal and pediatric pheno-
type that might be expected and thus provides a counsel-
ing challenge.
There has been a rapid growth in the diagnosis of this
condition with many suspected cases of KBG syndrome,
or children with learning disabilities undergoing exome
sequencing demonstrating partial gene deletions or single
gene loss at ANKRD11. The case we report has loss of
1.86 Mb at chromosome 16 band q24.2q24.3. This larger
deletion allowed identification through CMA rather than
exome sequencing; however, there are very few cases in
the literature of children and adults with a deletion of this
size. Two cases are reported by Goldenberg et al. [6] with
a similar loss to our case of ANKRD11 and the surround-
ing genes, and these children had more severe phenotypes
with multiple abnormalities and learning disabilities. Since
our case, a further review by Novara et al. [7] identified
12 cases with haploinsufficiency for ANKRD11-flanking
genes and reported a difference between KBG syndrome
and 16q24.3 microdeletion syndromes which are postu-
lated to have more severe phenotypes.
With the rapid expansion of prenatal diagnosis, and
the potential to perform exome sequencing in the antena-
tal period, we must continue to carefully describe the
Figure 1. (A) Ultrasound scan image of fetus at 21 weeks showing calcified foci in the upper abdomen (liver). (B) Postmortem X-ray of the
irregularity of the upper cervical vertebrae.
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genetic abnormalities, antenatal ultrasound findings, and
the postnatal phenotype concurrently to facilitate the
challenges in prenatal counseling and allow accurate and
clear counseling to patients.
Reiff et al. [8] have previously described that parents of
children undergoing CMA testing for suspected genetic
anomalies struggle to understand the scientific uncertainty
relating to the results they receive irrespective of whether
findings are of known pathogenic contribution or are
variants of uncertain significance (VOUS). This is particu-
larly evident where the pathogenic alteration is rare or
newly discovered, or if the availability of prognostic evi-
dence is limited [8]. Uncertain knowledge has been
described as “toxic” by participants in a study by Ber-
hardt et al. [9] who interviewed women at increased risk
of congenital fetal anomaly following prenatal CMA test-
ing. In retrospect, participants in this research wished
they had not received uncertain information and were left
feeling anxious with concerns that lingered following their
child’s birth [9]. The stress that parents experience when
opting for prenatal diagnosis may be intensified by the
complex and often ambiguous results arising from the
technology, thus clear and accurate verbal and written
communication by health professionals is paramount.
Appropriate pre and post-test counseling can help parents
understand the types of findings that may be returned to
them, and is central to supporting informed decision
making [10]. Managing uncertainty in relation to genetic
results will continue to present challenges for clinicians
[10, 11] and complicate parental decisions in pregnancy
[9]. In time, prenatal counseling around prognosis relat-
ing to many genetic alterations will be improved as fur-
ther phenotypic data are gathered leading to better
parental understanding and experience [11].
Conclusion
We present the first antenatal diagnosis of KBG syn-
drome, potentially demonstrating a more severe pheno-
type that is associated with complete loss of ANKRD11
and the surrounding genes, which includes triangularly
shaped face, low-set ears, retained testis, cervical ribs,
irregularity of the vertebral bodies, incomplete lobation of
the lungs, lobulated spleen, and calcification of the liver
associated with the portal tracts.
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